Erratum to: Subgroup analysis of the AFTER I-O study: a retrospective study on the efficacy and safety of subsequent molecular targeted therapy after immune-oncology therapy in Japanese patients with metastatic renal cell carcinoma.

Jpn J Clin Oncol

Department of Urology, Keio University School of Medicine, Tokyo, Japan.

Published: December 2021

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643447	PMC
http://dx.doi.org/10.1093/jjco/hyab161	DOI Listing

Publication Analysis

erratum subgroup

subgroup analysis

analysis i-o

i-o study

study retrospective

retrospective study

study efficacy

efficacy safety

safety subsequent

subsequent molecular

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!